Pregled bibliografske jedinice broj: 726837
Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer (MCC)
Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer (MCC) // ASCO Annual Meeting
San Antonio (TX), Sjedinjene Američke Države, 2009. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 726837 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer (MCC)
Autori
Vrdoljak, E ; Omrčen, T ; Hrabar, A ;
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
ASCO Annual Meeting
Mjesto i datum
San Antonio (TX), Sjedinjene Američke Države, 2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
metastatic colorectal cancer
Sažetak
Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer (MCC)
Izvorni jezik
Engleski
